A Study to Investigate the Effects of Food and Morning Versus Evening on Single and Multiple Doses of ONO-5334 in Healthy Post Menopausal Women

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2012

Conditions
Healthy Post Menopausal Women
Interventions
DRUG

ONO-5334

150 mg for 5 days administered in the morning or in the evening

DRUG

ONO-5334

150 mg QD for one day. Administered either in the fasted state or after the standard meal or high fat meal.

Trial Locations (2)

GU2 7XP

Guildford Clinical Site, Guildford

SE1 1YR

London Clinical Site, London

Sponsors
All Listed Sponsors
lead

Ono Pharmaceutical Co. Ltd

INDUSTRY